Kim Sablich

Kim Sablich

Former Executive Vice President and General Manager, USatJazz Pharmaceuticals· In proxies 2021–2023

Pay in FY2023-3% from the year before · Jazz Pharmaceuticals stock -22.8% the same year

Kim Sablich was paid $4.2M in FY2023 (Dec), down 3%. Jazz Pharmaceuticals stock fell 22.8% that year.

Pay$100 in the stock at the end of FY20 → $75
Pay is from the Summary Compensation Table of each Jazz Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Jazz PharmaceuticalsPublic company · 5 yr
    • Former Executive Vice President and General Manager, US2021 – Present · 5 yrStock in role +30%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?